Evidence map›Paper›PMID 39755842›Full record

ArticleDiabetologia2025

Eating disorders among people with and without type 1 diabetes: incidence and treatment in a nationwide population-based cohort.

Leon Hirvelä, Jari Haukka, Anna Keski-Rahkonen, Pyry N Sipilä

Abstract read
In one paragraph

Article in Diabetologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Leon HirveläDepartment of Public Health, University of Helsinki, Helsinki, Finland. leon.hirvela@helsinki.fi.ORCID http://orcid.org/0000-0001-6941-9123
Jari HaukkaDepartment of Public Health, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0003-1450-6208
Anna Keski-RahkonenDepartment of Public Health, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-6713-7488
Pyry N SipiläDepartment of Public Health, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0003-4886-8151

Funding

CARING study EU grant agreement number 282526Maud Kuistilan Muistosäätiö 2024-0135BSuomen Kulttuurirahasto 00220329
6 · The paper itself

Abstract

aims/hypothesisEating disorders are over-represented in type 1 diabetes and are associated with an increased risk of complications, but it is unclear whether type 1 diabetes affects the treatment of eating disorders. We assessed incidence and treatment of eating disorders in a nationwide sample of individuals with type 1 diabetes and diabetes-free control individuals.

methodsOur study comprised 11,055 individuals aged <30 who had been diagnosed with type 1 diabetes in 1998-2010, and 11,055 diabetes-free control individuals matched for age, sex and hospital district. We ascertained incidence of eating disorders from hospital records using Poisson regression. Eating disorder treatment was assessed by new prescriptions for psychotropic medications and hospital treatment for eating disorders.

resultsDuring a mean follow-up of 13.1 years, there were 175 incident cases of eating disorders among individuals with type 1 diabetes and 75 among the control individuals (adjusted incidence rate ratio 2.35; 95% CI 1.80, 3.09). The prescription of psychotropic medications was similar among eating disorder patients with and without type 1 diabetes. However, those with type 1 diabetes received outpatient hospital treatment for their eating disorder less often than those without diabetes (mean 3.32 vs 5.33 outpatient care visits per year [adjusted difference 1.24; 95% CI 0.39, 2.08]). CONCLUSIONS/

interpretationPeople with type 1 diabetes are more likely to be diagnosed with eating disorders than their diabetes-free peers. However, they receive less outpatient hospital treatment for their eating disorders despite their greater risk for major adverse health outcomes. These findings emphasise the need for targeted eating disorder treatment for people with type 1 diabetes.

Indexed as

Diabetes Mellitus, Type 1Feeding and Eating DisordersAdolescentAdultCohort StudiesFemaleHumansIncidenceMalePsychotropic DrugsYoung AdultPsychotropic DrugsEating disordersHospital treatmentIncidencePsychotropic medicationsType 1 diabetes

Identifiers

PMID39755842
PMCPMC11950106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.